Abstract:CRISPR systems have been proven as versatile tools for site-specific genome engineering in mammalian species. During the gene editing processes, these RNA-guide nucleases introduce DNA double strand breaks (DSBs), in which non-homologous DNA end joining (NHEJ) dominates the DNA repair pathway, limiting the efficiency of homology-directed repair (HDR), the alternative pathway essential for precise gene targeting. Multiple approaches have been developed to enhance HDR, including chemical compound or RNA interference-mediated inhibition of NHEJ factors, small molecule activation of HDR enzymes, or cell cycle timed delivery of CRISPR complex. However, these approaches face multiple challenges, yet have moderate or variable effects. Here we developed a new approach that programs both NHEJ and HDR pathways with CRISPR activation and interference (CRISPRa/i) to achieve significantly enhanced HDR efficiency of CRISPR-mediated gene editing. The manipulation of NHEJ and HDR pathway components, such as CtIP, CDK1, KU70, KU80, and LIG4, was mediated by catalytically dead guide RNAs (dgRNAs), thus relying on only a single catalytically active Cas9 to perform both CRISPRa/i and precise gene editing. While reprogramming of most DNA repair factors or their combinations tested enhanced HDR efficiency, simultaneously activating CDK1 and repressing KU80 has the strongest effect with increased HDR rate upto an order of magnitude. Doxycycline-induced dgRNA-based CRISPRa/i programming of DNA repair enzymes, as well as viral packaging enabled flexible and tunable HDR enhancement for broader applicability in mammalian cells. Our study provides an effective, flexible, and potentially safer strategy to enhance precise genome modifications, which might broadly impact human gene editing and therapy.

Template-based eukaryotic genome editing directed by SviCas3

SgRNA Engineering for Improved Genome Editing and Expanded Functional Assays.

Prokaryotic genome editing based on the subtype I-B-Svi CRISPR-Cas system

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in <i>Streptomyces</i>

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

Efficient genome engineering in eukaryotes using Cas9 from Streptococcus thermophilus.

An engineered Cas12i nuclease that is an efficient genome editing tool in animals and plants

Improved genome editing by an engineered CRISPR-Cas12a

RNA-Guided Human Genome Engineering via Cas9

Base editing in Streptomyces with Cas9 deaminase fusions

Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes

Chimeric CRISPR-CasX enzymes and guide RNAs for improved genome editing activity

Structure and genome editing of type I-B CRISPR-Cas

Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9

High-Throughput Profiling of Cas12a Orthologues and Engineered Variants for Enhanced Genome Editing Activity

In vivo genome editing using Staphylococcus aureus Cas9

Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family

Methods for in vitro CRISPR/CasRx-Mediated RNA Editing

Implementation of the CRISPR-Cas13a system in fission yeast and its repurposing for precise RNA editing.

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control